Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-12-181669
Filing Date
2012-04-25
Accepted
2012-04-25 14:43:01
Documents
4
Period of Report
2012-05-30
Effectiveness Date
2012-04-25

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d299196ddef14a.htm DEF 14A 643826
2 GRAPHIC g299196g40e39.jpg GRAPHIC 95915
3 GRAPHIC g299196g67v78.jpg GRAPHIC 88675
4 GRAPHIC g299196g97e79.jpg GRAPHIC 58387
  Complete submission text file 0001193125-12-181669.txt   980099
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34207 | Film No.: 12779242
SIC: 2834 Pharmaceutical Preparations